Dermatitis News

A study investigating the causes of eyelid allergic dermatitis found a common correlation with glaucoma medications, topical cosmetics and skin care products. A short course of topical corticosteroids was effective as a treatment in most cases.

The FDA’s approval of Tremfya for treating adults with moderate-to-severe psoriasis who are candidates for systemic therapy or phototherapy was among recent developments reported on Healio.com/Dermatology.

Regeneron Pharmaceuticals and Sanofi announced that the European Medicine Agency's Committee for Medicinal Products for Human Use has given a positive opinion for the marketing authorization of Dupixent in Europe for adults with moderate-to-severe atopic dermatitis who are candidates for systemic therapy.

Patients with rosacea experienced significantly higher prevalence and degrees of Demodex mite infestation when compared with healthy controls, according to study results published in the Journal of the American Academy of Dermatology.

African-Americans with mycosis fungoides experienced poorer overall survival than white or Asian patients, according to recent findings.

Dermavant Sciences has announced the appointment of Jacqualyn "Jackie" Fouse, PhD, as its executive chairman.

Prescription costs for acne and rosacea medications for Medicare patients were higher from specialists compared with primary care physicians in family medicine or internal medicine, according to recently published study results in the Journal of the American Academy of Dermatology.

Foamix Pharmaceuticals Ltd. recently announced that its board of directors has named David Domzalski as CEO, effective immediately.

The FDA’s approval of Baxdela for treating acute bacterial skin and skin structure infections was among the top read articles of the past week on Healio.com/Dermatology.

Patients with atopic dermatitis had health-related quality of life and productivity impairment that was comparable to patients with psoriasis, according to recently published study results in the Journal of the American Academy of Dermatology.